Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 56

Sort by

Sort Order Select

Journal Articles

Intraclonal Heterogeneity Caused By Activation-Induced Cytidine Deaminase Is Not a Prognostic Biomarker in Untreated Advanced Stage Follicular Lymphoma: An Analysis of SWOG S0016

Richard Burack, MD PhD, Hongli Li, MS, Diana G Adlowitz, PhD, Janice M Spence, PhD, Michael L. Leblanc, PhD, Lisa M. Rimsza, MD, Rita M. Braziel, MD, Catherine M. Spier, MD, Mark S Kaminski, MD, John P. Leonard, MD, Richard I. Fisher, MD, Sonali M. Smith, MD, Jonathan W. Friedberg, MD

Blood (2019) 134 (Supplement_1): 2771.

https://doi.org/10.1182/blood-2019-121632

Published: 2019

Journal Articles

Genetic drivers of oncogenic pathways in molecular subgroups of peripheral T-cell lymphoma

Blood (2019) 133 (15): 1664–1676.

https://doi.org/10.1182/blood-2018-09-872549

Published: 2019

Includes: Supplemental data

Journal Articles

Genomic alterations important for the prognosis in patients with follicular lymphoma treated in SWOG study S0016

Xiaoyu Qu, Hongli Li, Rita M. Braziel, Verena Passerini, Lisa M. Rimsza, Eric D. Hsi, John P. Leonard, Sonali M. Smith, Robert Kridel, Oliver Press, Oliver Weigert, Michael LeBlanc, Jonathan W. Friedberg, Min Fang

Blood (2019) 133 (1): 81–93.

https://doi.org/10.1182/blood-2018-07-865428

Published: 2019

Includes: Supplemental data

Journal Articles

Subclonal Mutations of TP53 Are Common in Untreated Follicular Lymphoma and Mutation Status Is Predictive of PFS When CHOP Is Combined with 131-Iodine Tositumomab but Not with Rituximab: An Analysis of SWOG S0016

Richard Burack, MD PhD, Hongli Li, MS, Janice M Spence, PhD, Diana Adlowitz, Lisa M. Rimsza, MD, Rita M. Braziel, MD, Catherine M. Spier, MD, Mark S Kaminski, MD, John P. Leonard, MD, Richard I. Fisher, MD, Michael L. Leblanc, PhD, Sonali M. Smith, MD, Jonathan W. Friedberg, MD

Blood (2018) 132 (Supplement 1): 919.

https://doi.org/10.1182/blood-2018-99-111399

Published: 2018

Journal Articles

Molecular classification of primary mediastinal large B-cell lymphoma using routinely available tissue specimens

Blood (2018) 132 (22): 2401–2405.

https://doi.org/10.1182/blood-2018-05-851154

Published: 2018

Includes: Supplemental data

Journal Articles

Genomic Alterations Important for the Prognosis in Patients with Follicular Lymphoma Treated on SWOG Study S0016

Xiaoyu Qu, PhD, Hongli Li, MS, Oliver W. Press, MD PhD, Lisa M. Rimsza, MD, Rita M. Braziel, MD, Michael L. Leblanc, PhD, Eric D. Hsi, MD, John P. Leonard, MD, Sonali M. Smith, MD, Jonathan W. Friedberg, MD, Min Fang, MDPhD

Blood (2017) 130 (Supplement 1): 1507.

https://doi.org/10.1182/blood.V130.Suppl_1.1507.1507

Published: 2017

Journal Articles

Adult high-grade B-cell lymphoma with Burkitt lymphoma signature: genomic features and potential therapeutic targets

Blood (2017) 130 (16): 1819–1831.

https://doi.org/10.1182/blood-2017-02-767335

Published: 2017

Includes: Supplemental data

Journal Articles

Comprehensive Genomic Analysis of Adult Burkitt Lymphoma Identifies the B-Cell Receptor Signaling Pathway As a Potential Therapeutic Target

Blood (2016) 128 (22): 4095.

https://doi.org/10.1182/blood.V128.22.4095.4095

Published: 2016

Journal Articles

Molecular Subgroups of Peripheral T-Cell Lymphoma Evolve By Distinct Genetic Pathways

Blood (2016) 128 (22): 4096.

https://doi.org/10.1182/blood.V128.22.4096.4096

Published: 2016

Journal Articles

Continued Excellent Outcomes in Previously Untreated Follicular Lymphoma Patients after Treatment with CHOP Plus Rituximab or CHOP Plus (131) Iodine-Tositumomab - Long Term Follow-up of Phase III Randomized Study SWOG S0016

Mazyar Shadman, MD MPH, Hongli Li, PhD, Lisa Rimsza, MD, John P. Leonard, MD, Mark S Kaminski, MD, Rita M Braziel, MD, Catherine M. Spier, MD, Ajay K Gopal, MD, David G Maloney, MD PhD, Bruce Cheson, MD, Shaker Dakhil, MD FACP, Michael LeBlanc, PhD, Sonali M. Smith, MD, Richard I. Fisher, MD, Jonathan W. Friedberg, MD, Oliver Press, MD PhD

Blood (2016) 128 (22): 616.

https://doi.org/10.1182/blood.V128.22.616.616

Published: 2016

Journal Articles

Genomic Alterations Important for the Prognosis in Patients with Follicular Lymphoma Treated on SWOG Study S0016

Xiaoyu Qu, PhD, Hongli Li, PhD, Oliver W Press, MD PhD, Lisa M. Rimsza, MD, Rita M. Braziel, MD, Michael Leblanc, PhD, Eric D. Hsi, MD, Sonali M. Smith, MD, Jonathan W. Friedberg, MD MMSc, Min Fang, MD PhD

Blood (2015) 126 (23): 2678.

https://doi.org/10.1182/blood.V126.23.2678.2678

Published: 2015

Journal Articles

Analytical Performance of Nanostring's Companion Diagnostic (CDx) Lymphoma Subtyping Test (LST) with Diffuse Large B-Cell Lymphoma Core Needle Biopsy Samples

James Storhoff, Brett Wallden, Rita M. Braziel, Catherine Thieblemont, Tressa Hood, Harini Ravi, Shannon Dennis, Naeem Dowidar, Patrick Danaher, Jennifer Dunlap, MD, Josette Briere, Eric de Kerviler, Sean Ferree

Blood (2015) 126 (23): 1481.

https://doi.org/10.1182/blood.V126.23.1481.1481

Published: 2015

Journal Articles

Global microRNA expression profiling uncovers molecular markers for classification and prognosis in aggressive B-cell lymphoma

Blood (2015) 125 (7): 1137–1145.

https://doi.org/10.1182/blood-2014-04-566778

Published: 2015

Includes: Supplemental data

Journal Articles

Accurate Diagnosis of Aggressive B Cell Non-Hodgkin Lymphomas Using Gene Expression Profiling of Formalin-Fixed, Paraffin-Embedded Tissues

Blood (2014) 124 (21): 3016.

https://doi.org/10.1182/blood.V124.21.3016.3016

Published: 2014

Journal Articles

Cell-of-Origin Subtype Classification of Diffuse Large B-Cell Lymphoma Using the Lymph2Cx Assay Retains Relevance in the Context of BCL2 and MYC Expression Status

Samantha L. Kendrick, PhD, Katalin Tus, MD, David W. Scott, MBChB, PhD, George Wright, PhD, Elaine S. Jaffe, MD, Andreas Rosenwald, MD, Elías Campo, MD PhD, Wing Chung Chan, MD, Joseph M. Connors, MD, Rita M. Braziel, MD, German Ott, MD, Jan Delabie, MD PhD, James R. Cook, MD PhD, Dennis D. Weisenburger, MD, Timothy C. Greiner, MS, MD, Kai Fu, MD PhD, Louis M. Staudt, MD PhD, Randy D. Gascoyne, MD, Lisa M. Rimsza, MD

Blood (2014) 124 (21): 1667.

https://doi.org/10.1182/blood.V124.21.1667.1667

Published: 2014

Journal Articles

Consolidative Autologous Stem Cell Transplant for Double Hit Lymphoma

Andy I Chen, MDPhD, Craig Okada, MD PhD, Nate Gay, MD, Phil Reiss, MD, Stephen Spurgeon, MD, Guang Fan, MD PhD, Rita M. Braziel, MD, Richard T. Maziarz, MD

Blood (2014) 124 (21): 3993.

https://doi.org/10.1182/blood.V124.21.3993.3993

Published: 2014

Journal Articles

Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphoma

Blood (2014) 123 (19): 2915–2923.

https://doi.org/10.1182/blood-2013-11-536359

Published: 2014

Includes: Supplemental data

Journal Articles

Genome-wide copy-number analyses reveal genomic abnormalities involved in transformation of follicular lymphoma

Blood (2014) 123 (11): 1681–1690.

https://doi.org/10.1182/blood-2013-05-500595

Published: 2014

Includes: Supplemental data

Journal Articles

Determining cell-of-origin subtypes of diffuse large B-cell lymphoma using gene expression in formalin-fixed paraffin-embedded tissue

Blood (2014) 123 (8): 1214–1217.

https://doi.org/10.1182/blood-2013-11-536433

Published: 2014

Includes: Supplemental data

Journal Articles

Determining Cell-Of-Origin Subtypes In Diffuse Large B-Cell Lymphoma Using Gene Expression Profiling On Formalin-Fixed Paraffin-Embedded Tissue – An L.L.M.P.P. Project

Blood (2013) 122 (21): 73.

https://doi.org/10.1182/blood.V122.21.73.73

Published: 2013

NARROW

Intraclonal Heterogeneity Caused By Activation-Induced Cytidine Deaminase Is Not a Prognostic Biomarker in Untreated Advanced Stage Follicular Lymphoma: An Analysis of SWOG S0016

Genetic drivers of oncogenic pathways in molecular subgroups of peripheral T-cell lymphoma

Genomic alterations important for the prognosis in patients with follicular lymphoma treated in SWOG study S0016

Subclonal Mutations of TP53 Are Common in Untreated Follicular Lymphoma and Mutation Status Is Predictive of PFS When CHOP Is Combined with 131-Iodine Tositumomab but Not with Rituximab: An Analysis of SWOG S0016

Molecular classification of primary mediastinal large B-cell lymphoma using routinely available tissue specimens

Genomic Alterations Important for the Prognosis in Patients with Follicular Lymphoma Treated on SWOG Study S0016

Adult high-grade B-cell lymphoma with Burkitt lymphoma signature: genomic features and potential therapeutic targets

Comprehensive Genomic Analysis of Adult Burkitt Lymphoma Identifies the B-Cell Receptor Signaling Pathway As a Potential Therapeutic Target

Molecular Subgroups of Peripheral T-Cell Lymphoma Evolve By Distinct Genetic Pathways

Continued Excellent Outcomes in Previously Untreated Follicular Lymphoma Patients after Treatment with CHOP Plus Rituximab or CHOP Plus (131) Iodine-Tositumomab - Long Term Follow-up of Phase III Randomized Study SWOG S0016

Genomic Alterations Important for the Prognosis in Patients with Follicular Lymphoma Treated on SWOG Study S0016

Analytical Performance of Nanostring's Companion Diagnostic (CDx) Lymphoma Subtyping Test (LST) with Diffuse Large B-Cell Lymphoma Core Needle Biopsy Samples

Global microRNA expression profiling uncovers molecular markers for classification and prognosis in aggressive B-cell lymphoma

Accurate Diagnosis of Aggressive B Cell Non-Hodgkin Lymphomas Using Gene Expression Profiling of Formalin-Fixed, Paraffin-Embedded Tissues

Cell-of-Origin Subtype Classification of Diffuse Large B-Cell Lymphoma Using the Lymph2Cx Assay Retains Relevance in the Context of BCL2 and MYC Expression Status

Consolidative Autologous Stem Cell Transplant for Double Hit Lymphoma

Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphoma

Genome-wide copy-number analyses reveal genomic abnormalities involved in transformation of follicular lymphoma

Determining cell-of-origin subtypes of diffuse large B-cell lymphoma using gene expression in formalin-fixed paraffin-embedded tissue

Determining Cell-Of-Origin Subtypes In Diffuse Large B-Cell Lymphoma Using Gene Expression Profiling On Formalin-Fixed Paraffin-Embedded Tissue – An L.L.M.P.P. Project

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only